Janel Corporation

Janel Corporation, through its subsidiaries, provides logistics services worldwide. It operates in three segments: Logistics, Manufacturing, and Life Sciences. The Logistics segment provides cargo transportation logistics management services, including freight forwarding by air, ocean, and land-based carriers; customs brokerage services; warehousing and distribution services; and other value added logistic services, as well as customs entry filing, cargo insurance procurement, logistics planning, product repackaging, and online shipment tracking services. The Manufacturing segment manufactures and distributes mixing equipment and apparatus for various industries, such as chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immuno-reagents for biomedical research; provides antibody manufacturing for academic and industry research scientists; and produces products for other life science companies on an original equipment manufacturer basis. The company was formerly known as Janel World Trade Ltd. and changed its name to Janel Corporation in April 2015. Janel Corporation was founded in 1974 and is headquartered in New York, New York.

Janel Corporation trades as JANL on OTC. The company is classified in Industrials / Integrated Freight & Logistics and reports in USD.

The current profile places the business in Integrated Freight & Logistics. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $207.44M of revenue and $5.41M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Janel Corporation can be compared against peers such as Atlas Engineered Products Ltd., Veloryx Ltd., Genoil Inc., Kingsmen Creatives Ltd., Northstar Clean Technologies Inc., Suncorp Technologies Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $53.39M, beta of -0.29, and return on equity of +21.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

JANL currently shows total debt of $23.24M and beta of -0.29. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 4 (2026-06-04 00:00:00), 4 (2026-05-29 00:00:00), 4 (2026-05-15 00:00:00), 10-Q (2026-05-08 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.janelcorp.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.